Tuesday 21 August 2018 ,
Tuesday 21 August 2018 ,
Latest News
  • Road crashes claim 15 lives in Narsingdi, Feni
  • 52 Bangladeshis pilgrims have so far died in Saudi
  • Safe road movement: 9 more students freed from Keraniganj jail
  • Khalishpur Meghna oil depot catches fire, 3 killed
  • Truck-microbus collision kills 6 in Feni
  • Myanmar tactfully delaying Rohingya repatriation
  • Movement for safe roads: 25 students get bail
5 February, 2018 00:00 00 AM
Print

Novo Nordisk and Eskayef signs (MoU) to transfer Danish state-of-the-art technology to Bangladesh for advanced insulin manufacturing

Stethoscope desk
Novo Nordisk and Eskayef signs (MoU) to transfer Danish state-of-the-art technology to Bangladesh for advanced insulin manufacturing

As an outcome of a high-level government delegation visit to Denmark in February last year, Novo Nordisk – the world’s largest insulin manufacturer has now agreed to transfer Danish advanced state-of-the-art insulin devices manufacturing technology to Bangladesh.

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given the company experience and capabilities to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 41,700 people in 77 countries and markets its products in more than 165 countries.

Mr Anand Shetty, Managing Director of Novo Nordisk Bangladesh and Ms Simeen Hossain, Managing Director of Eskayef Pharmaceutical Ltd. recently signed a Memorandum of Understanding (MoU) at a local hotel in Dhaka to set-up local manufacturing of human and modern insulin in cartridges in the presence of Zahid Malik, State Minister for Health and Family Welfare Ministry.

Eskayef has emerged as one of the leading pharmaceutical companies in Bangladesh. The state-of-the-art manufacturing facility of Eskayef has been approved by stringent global regulators including UK MHRA, European Medicines Agency, TGA Australia, VMD UK and UNICEF. Eskayef is growing globally and are already exporting their products to different countries in Asia, Africa, Europe and Australia.

Zahid Malik, State Minister for Health and Family Welfare Ministry, said: “Diabetes, one of the non-communicable diseases, poses a big threat to sustainable development. The growing number of patients living with diabetes is in constant need of proper care and timely treatment including the need for quality insulin supply at affordable price.”

Speaking on the occasion, Latifur Rahman, chairman, Transcom Group said: "The Danish state-of-the-art modern insulin manufacturing technology transfer is a matter of pride, not only for Eskayef but for the whole country. It has only been made possible due to Eskayef’s proven track record of strict adherence to quality.

“The partnership will further strengthen the bilateral relation between Denmark and Bangladesh. It is a historic event and Denmark is proud to be a partner and contribute to the advancement of this sector in Bangladesh,” said the Danish Ambassador to Bangladesh Mikael Hemniti Winther.

Lars Bo Smidt, Corporate Vice-President, Finance and Operations for Novo Nordisk’s Africa, Asia, Middle East and Oceania regions; S. M. Shafiuzzaman, General Secretary, Bangladesh Association of Pharmaceutical Industries; Kazi M. Aminul Islam, Executive Chairman, Bangladesh Investment Development Authority; Professor AK Azad Khan, President of Diabetic Association of Bangladesh and Roxana Quader, Additional Secretary (Public Health and World health Organization), Ministry of Health and Family Welfare were present at the programme.

 

 

Comments

Poll
Today's Question »
TIB has expressed concerns over a new act that restricts ACC powers in arresting govt officials. Do you support the anti-graft watchdog?
 Yes
 No
 No Comment
Yes 97.2%
No 2.1%
No Comment 0.7%
Most Viewed
Digital Edition
Archive
SunMonTueWedThuFri Sat
01020304
05060708091011
12131415161718
19202122232425
262728293031

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting